Wordt geladen...
Tumor-specific CD4(+) T cells maintain effector and memory tumor-specific CD8(+) T cells
Immunotherapies that augment antitumor T cells have had recent success for treating patients with cancer. Here we examined whether tumor-specific CD4(+) T cells enhance CD8(+) T-cell adoptive immunotherapy in a lymphopenic environment. Our model employed physiological doses of tyrosinase-related pro...
Bewaard in:
| Gepubliceerd in: | Eur J Immunol |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BlackWell Publishing Ltd
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4283993/ https://ncbi.nlm.nih.gov/pubmed/24114780 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/eji.201343718 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|